Open Menu Open Menu

    St. Thomas Law Review

    Contract Law

    Business LawContract LawFeaturedFlorida Law

    Silencing the Departed: Limits on Non-Disparagement Clauses in Employment and Severance Contracts in Florida

    October 22, 2025By Stephanie Gudiel

    Non-disparagement clauses in employment agreements and severance packages have become common. When an employee departs, particularly involuntarily, an employer often offers a severance package contingent on signing a release of claims and a promise not to make negative statements about the company.[i] These clauses are marketed as a way to protect an organization’s reputation. However, […]

    Read More

    Contract LawFamily LawFeaturedIntellectual Property

    Taylor Swift and Travis Kelce’s Engagement: The Importance of Prenups

    October 6, 2025By Sophia Borrello

    What began with a friendship bracelet ended with an engagement ring. Taylor Swift, a fourteen-time Grammy Award-winning singer and songwriter, and Travis Kelce, a Kansas City Chiefs football player and a three-time Super Bowl champion, captured national attention with their engagement announcement.[i] As their relationship became public, media coverage showcased it as a modern-day love […]

    Read More

    Contract LawFeaturedFederal Trade Commission

    Freedom to Contract or Freedom to Financially Oppress? A Look at Delaware’s Denial of Reasonableness Review in Forfeiture-for-Competition Clauses

    March 28, 2025By Nathalie Tirado

      Since the 1900s, Delaware has been considered the leading state in corporate law with business-friendly legal frameworks. In fact, most states routinely cite Delaware corporate law and structure their laws similarly to Delaware. As of today, Delaware is the legal home of over two million corporate entities, and these entities are governed by Delaware’s […]

    Read More

    Contract LawFeaturedHealth CarePharmaceuticals

    House Blocks Chinese Biotech: Great Wall Built, but Who Guarded the Supply Chain?

    October 21, 2024By Chelsea Barcenas

      On September 9, 2024, the U.S. House of Representatives voted 306-81 in favor of H.R. 8333, known as the Biosecure Act.[i]  The Biosecure Act prohibits U.S. companies from entering into contracts with biotechnology “companies of concern” and their U.S. subsidiaries.[ii] Specifically, the bill blocks partnerships with BGI Group, MGI, WuXi AppTec, WuXi Biologics, and […]

    Read More

    Back to Top